Projecting Pharmaceutical Expenditure in EU5 to 2021: Adjusting for the Impact of Discounts and Rebates

BACKGROUND: Within (European) healthcare systems, the predominant goal for pharmaceutical expenditure is cost containment. This is due to a general belief among healthcare policy makers that pharmaceutical expenditure—driven by high prices—will be unsustainable unless further reforms are enacted. OB...

Descripción completa

Detalles Bibliográficos
Autores principales: Espin, Jaime, Schlander, Michael, Godman, Brian, Anderson, Pippa, Mestre-Ferrandiz, Jorge, Borget, Isabelle, Hutchings, Adam, Flostrand, Steven, Parnaby, Adam, Jommi, Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6244625/
https://www.ncbi.nlm.nih.gov/pubmed/30088251
http://dx.doi.org/10.1007/s40258-018-0419-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6244625/
https://www.ncbi.nlm.nih.gov/pubmed/30088251
http://dx.doi.org/10.1007/s40258-018-0419-1

Ejemplares similares